Previous close | 0.2669 |
Open | 0.2700 |
Bid | 0.2601 x 800 |
Ask | 0.2697 x 4000 |
Day's range | 0.2633 - 0.2895 |
52-week range | 0.2080 - 1.9120 |
Volume | |
Avg. volume | 1,341,990 |
Market cap | 33.782M |
Beta (5Y monthly) | 2.03 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3120 |
Earnings date | 10 Aug 2022 - 15 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.98 |
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of 11.11% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Corcept (CORT) posts overall survival data from a phase II study evaluating relacorilant plus nab-paclitaxel for treating recurrent platinum-resistant ovarian cancer.
Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals are part of today's Screen of the Week blog.